Hyperosmolar coma in a patient with hypothalamic Langerhans cell histiocytosis

Endocrine. 2016 Apr;52(1):176-7. doi: 10.1007/s12020-015-0675-x. Epub 2015 Jul 7.

Authors

Ivan Kruljac¹, Goran Rinčić², Hrvoje Ivan Pećina³

Affiliations

¹ Department of Endocrinology, Diabetes and Metabolic Diseases "Mladen Sekso", University Hospital Center "Sestre Milosrdnice", University of Zagreb Medical School, Vinogradska Cesta 29, 10000, Zagreb, Croatia. ivkruljac@gmail.com.
² Department of Hematology, University Hospital Center "Sestre Milosrdnice", Zagreb, Croatia.
³ Department of Radiology, University Hospital Center "Sestre Milosrdnice", Zagreb, Croatia.

PMID: 26148702
DOI: 10.1007/s12020-015-0675-x

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Diabetes Insipidus, Nephrogenic / complications
Diabetes Insipidus, Nephrogenic / drug therapy
Diabetes Mellitus, Type 2 / complications
Female
Fluid Therapy
Histiocytosis, Langerhans-Cell / complications*
Histiocytosis, Langerhans-Cell / drug therapy
Humans
Hyperglycemic Hyperosmolar Nonketotic Coma / drug therapy
Hyperglycemic Hyperosmolar Nonketotic Coma / etiology*
Hypothalamic Neoplasms / complications
Hypothalamic Neoplasms / diagnostic imaging
Hypothalamic Neoplasms / drug therapy
Magnetic Resonance Imaging
Middle Aged
Remission Induction